Terumo Corporation (TRUMF)

Market Cap	19.01B -31.0%
Revenue (ttm)	6.99B +8.3%
Net Income	815.77M +2.2%
EPS	0.55 +2.8%
Shares Out	n/a
PE Ratio	23.30
Forward PE	n/a
Dividend	0.19 (1.55%)
Ex-Dividend Date	Mar 30, 2026

Volume	1,100
Average Volume	65,191
Open	12.50
Previous Close	12.62
Day's Range	12.40 - 12.62
52-Week Range	12.34 - 20.58
Beta	0.23
RSI	46.81
Earnings Date	May 15, 2026

About Terumo

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. It operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems,...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1921
• Employees: 28,294
• Stock Exchange: OTCMKTS
• Ticker Symbol: TRUMF

Financial Performance

In fiscal year 2025, Terumo's revenue was 1.04 trillion, an increase of 12.40% compared to the previous year's 921.86 billion. Earnings were 116.98 billion, an increase of 9.97%.

Financial numbers in JPY